Abstract
MicroRNAs (miRNAs) comprise an important class of small single-stranded non-coding RNAs that regulate several important biological processes, including cell differentiation, growth, and apoptosis. The dysregulations of miRNAs are usually correlated with several diseases because of their regulatory functions in organisms. Over the past few years, miRNAs are often observed to be aberrantly expressed in cancers, indicating their potential correlations with cancer pathogenesis. Recently, evidence has increased to prove this assumption. Further investigations show that miRNAs are involved extensively in various cancer cell processes on the molecular level, including promotions of cancer cell development. Considering the important functions of miRNAs in cancer development, investigating the relationship between miRNAs and cancers can lead to a better understanding of the latter. Therefore, this review summarizes recent developments from related studies, particularly focusing on the functions of miRNAs and their potential applications as therapeutic strategies for cancers.
Keywords: Cancer, microRNAs, oncogenes, prognosis, tumor suppressors.
Current Bioinformatics
Title:A Discussion of MicroRNAs in Cancers
Volume: 9 Issue: 5
Author(s): Shi Hua, Wu Yun, Zeng Zhiqiang and Quan Zou
Affiliation:
Keywords: Cancer, microRNAs, oncogenes, prognosis, tumor suppressors.
Abstract: MicroRNAs (miRNAs) comprise an important class of small single-stranded non-coding RNAs that regulate several important biological processes, including cell differentiation, growth, and apoptosis. The dysregulations of miRNAs are usually correlated with several diseases because of their regulatory functions in organisms. Over the past few years, miRNAs are often observed to be aberrantly expressed in cancers, indicating their potential correlations with cancer pathogenesis. Recently, evidence has increased to prove this assumption. Further investigations show that miRNAs are involved extensively in various cancer cell processes on the molecular level, including promotions of cancer cell development. Considering the important functions of miRNAs in cancer development, investigating the relationship between miRNAs and cancers can lead to a better understanding of the latter. Therefore, this review summarizes recent developments from related studies, particularly focusing on the functions of miRNAs and their potential applications as therapeutic strategies for cancers.
Export Options
About this article
Cite this article as:
Hua Shi, Yun Wu, Zhiqiang Zeng and Zou Quan, A Discussion of MicroRNAs in Cancers, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140804221135
DOI https://dx.doi.org/10.2174/1574893609666140804221135 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Caffeic Acid, A Versatile Pharmacophore: An Overview
Mini-Reviews in Medicinal Chemistry STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3
Current Cancer Drug Targets The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
Current Pharmaceutical Design HOX Genes as Potential Markers of Circulating Tumour Cells
Current Molecular Medicine Edelfosine in Membrane Environment - the Langmuir Monolayer Studies
Anti-Cancer Agents in Medicinal Chemistry Other Potential Therapeutic Targets in Thyroid Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Oridonin, a Promising Antitumor Natural Product in the Chemotherapy of Hematological Malignancies
Current Pharmaceutical Biotechnology The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia
Current Medicinal Chemistry Ovarian Toxicity: From Environmental Exposure to Chemotherapy
Current Pharmaceutical Design An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry A Review of Recent Advancements in Anti-tubercular Molecular Hybrids
Current Medicinal Chemistry Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Current Drug Targets Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Current Signal Transduction Therapy Cationicity and Hydrophobicity Enhance the Cytotoxic Potency of Phoratoxin C Anticancer Peptide Analogues against Triple Negative Breast Cancer Cells
Current Bioactive Compounds Targeting Cancer Cells by an Oxidant-Based Therapy
Current Molecular Pharmacology Drug Targeting Strategies in Cancer Treatment: An Overview
Mini-Reviews in Medicinal Chemistry Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis
Current Drug Metabolism